XML 18 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Convertible note - related party
Convertible debt
Common Stock
Common Stock
Convertible note - related party
Convertible debt
Additional Paid-in Capital
Additional Paid-in Capital
Convertible note - related party
Convertible debt
Accumulated Other Comprehensive Loss
Accumulated Deficit
Non-controlling interests
Shares outstanding, beginning balance (in shares) at Dec. 31, 2023     139,705            
Equity, beginning balance at Dec. 31, 2023 $ 634,716   $ 1,397   $ 925,623   $ (18,826) $ (274,999) $ 1,521
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Share-based compensation expense 3,670       3,670        
Net loss (28,690)             (28,543) (147)
Reclassification of warrants from liability classified to equity classified 10       10        
Other comprehensive (loss) income (26,044)           (26,044)    
Shares outstanding, ending balance (in shares) at Mar. 31, 2024     139,705            
Equity, ending balance at Mar. 31, 2024 583,662   $ 1,397   929,303   (44,870) (303,542) 1,374
Shares outstanding, beginning balance (in shares) at Dec. 31, 2023     139,705            
Equity, beginning balance at Dec. 31, 2023 634,716   $ 1,397   925,623   (18,826) (274,999) 1,521
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (83,407)                
Shares outstanding, ending balance (in shares) at Sep. 30, 2024     140,490            
Equity, ending balance at Sep. 30, 2024 538,690   $ 1,405   929,324   (34,035) (358,004) 0
Shares outstanding, beginning balance (in shares) at Mar. 31, 2024     139,705            
Equity, beginning balance at Mar. 31, 2024 583,662   $ 1,397   929,303   (44,870) (303,542) 1,374
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Share-based compensation expense 1,486       1,486        
Net loss (27,161)             (26,987) (174)
Shares issued for debt conversion (in shares)     785            
Exercise of warrants 0   $ 8   (8)        
Other comprehensive (loss) income 4,862           4,862    
Shares outstanding, ending balance (in shares) at Jun. 30, 2024     140,490            
Equity, ending balance at Jun. 30, 2024 562,849   $ 1,405   930,781   (40,008) (330,529) 1,200
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Share-based compensation expense 1,554       1,554        
Net loss (27,556)             (27,475) (81)
Other comprehensive (loss) income 5,973           5,973    
Acquisition of non-controlling interest (4,130)       (3,011)       (1,119)
Shares outstanding, ending balance (in shares) at Sep. 30, 2024     140,490            
Equity, ending balance at Sep. 30, 2024 $ 538,690   $ 1,405   929,324   (34,035) (358,004) 0
Shares outstanding, beginning balance (in shares) at Dec. 31, 2024 155,928   155,928            
Equity, beginning balance at Dec. 31, 2024 $ 188,762   $ 1,559   971,416   (58,975) (725,238) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Share-based compensation expense 4,242       4,242        
Net loss (16,239)             (16,239)  
Exercise of stock options (in shares)     10            
Preferred stock dividends and accretion (891)       (891)        
Other comprehensive (loss) income 26,065           26,065    
Shares outstanding, ending balance (in shares) at Mar. 31, 2025     155,938            
Equity, ending balance at Mar. 31, 2025 $ 201,939   $ 1,559   974,767   (32,910) (741,477) 0
Shares outstanding, beginning balance (in shares) at Dec. 31, 2024 155,928   155,928            
Equity, beginning balance at Dec. 31, 2024 $ 188,762   $ 1,559   971,416   (58,975) (725,238) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss $ (178,707)                
Exercise of stock options (in shares) 700                
Shares outstanding, ending balance (in shares) at Sep. 30, 2025 168,626   168,626            
Equity, ending balance at Sep. 30, 2025 $ 96,905   $ 1,686   1,014,970   (15,806) (903,945) 0
Shares outstanding, beginning balance (in shares) at Mar. 31, 2025     155,938            
Equity, beginning balance at Mar. 31, 2025 201,939   $ 1,559   974,767   (32,910) (741,477) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Share-based compensation expense 1,285       1,285        
Net loss (31,909)             (31,909)  
Preferred stock dividends and accretion (891)       (891)        
Other comprehensive (loss) income 13,482           13,482    
Shares outstanding, ending balance (in shares) at Jun. 30, 2025     155,938            
Equity, ending balance at Jun. 30, 2025 183,906   $ 1,559   975,161   (19,428) (773,386) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Share-based compensation expense 1,883       1,883        
Net loss (130,559)             (130,559)  
Exercise of warrants (in shares)     157            
Exercise of warrants 0   $ 2   (2)        
Shares issued for debt conversion (in shares)       12,522          
Issuance of penny warrants 13,510       13,510        
Exercise of warrants   $ 33,139   $ 125   $ 33,014      
Exercise of stock options (in shares)     9            
Preferred stock dividends and accretion (819)       (819)        
Deemed dividends (7,777)       (7,777)        
Other comprehensive (loss) income $ 3,622           3,622    
Shares outstanding, ending balance (in shares) at Sep. 30, 2025 168,626   168,626            
Equity, ending balance at Sep. 30, 2025 $ 96,905   $ 1,686   $ 1,014,970   $ (15,806) $ (903,945) $ 0